The present invention relates to pharmaceutical compositions that include a targeting peptide, a protease specific cleavable peptide, and a chemotherapeutic drug that when conjugated are substantially inactive, but upon degradation of the cleavable sequence by a proteolytic enzyme abundant in or within the target cancer cell, the chemotherapeutic drug is released and becomes active, and to methods of use of these compositions for treatment of cancer.

 
Web www.patentalert.com

< Therapeutic device and method using feedback from implantable pressure sensor

> Ligand exchange thermochromic, (LETC), systems

> Triterpene compositions and methods for use thereof

~ 00571